Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily

Biogen (BIIB) Technical Analysis

4,550 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -4.25, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 184.36, while Biogen’s (BIIB) share price is $173.52, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 191.91, while Biogen’s (BIIB) share price is $173.52, making it a Sell.

Biogen (BIIB) Pivot Points

Nov 04, 2024, 08:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
166.49
170.18
172.09
175.78
177.69
181.38
183.29
Fibonacci
170.18
172.32
173.64
175.78
177.92
179.24
181.38
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Nov 04, 2024, 08:16 PM
Period
Simple
Exponential
MA5
179.49Sell
177.97Sell
MA10
181.65Sell
180.95Sell
MA20
184.84Sell
184.36Sell
MA50
192.72Sell
191.91Sell
MA100
205.67Sell
200.97Sell
MA200
213.81Sell
212.77Sell
Biogen’s (BIIB) 10-Day exponential moving average is 180.95, while Biogen’s (BIIB) share price is $173.52, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 200.97, while Biogen’s (BIIB) share price is $173.52, making it a Sell.
Biogen’s (BIIB) stock price is $173.52 and Biogen’s (BIIB) 50-day simple moving average is 192.72, creating a Sell signal.
Biogen’s (BIIB) stock price is $173.52 and Biogen’s (BIIB) 100-day simple moving average is 205.67, creating a Sell signal.
Biogen’s (BIIB) stock price is $173.52 and Biogen’s (BIIB) 200-day simple moving average is 213.81, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Nov 04, 2024, 08:16 PM
Name
Value
Implied Action
RSI (14)
29.30
Buy
STOCH (9,6)
9.92
Buy
STOCHRSI (14)
7.93
Buy
MACD (12,26)
-4.25
Buy
ADX (14)
26.86
Neutral
Williams %R
-96.90
Buy
CCI (14)
-216.92
Buy
ATR (14)
4.42
-
Ultimate Oscillator
29.46
Sell
ROC
-9.28
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 29.30, creating a Buy signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 26.86, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -216.92, creating a Buy signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -9.28, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 29.30, which suggests BIIB is a Buy.
      What is BIIB’s MACD?
      BIIB’s MACD is -4.25, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 179.49, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 184.84, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 192.72, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 213.81, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -96.90, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -216.92, which suggests BIIB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis